Interpretation of updated guidelines for colorectal cancer screening in average-risk individuals in the United States.
10.3760/cma.j.cn441530-20220220-00055
- Author:
Chen Qin LE
1
;
Cheng Cheng LIU
1
;
Ye Ting HU
1
;
Qian XIAO
1
;
Kefeng DING
2
Author Information
1. Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.
2. Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China Cancer Center Zhejiang University, Hangzhou 310058, China.
- Publication Type:Journal Article
- MeSH:
China;
Colorectal Neoplasms/epidemiology*;
Early Detection of Cancer;
Humans;
Mass Screening;
United States
- From:
Chinese Journal of Gastrointestinal Surgery
2022;25(9):826-833
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, due to changes in the epidemiology of colorectal cancer in the United States, the update of evidence-based medical evidence for screening, and the emergence of various new screening methods, various organizations in the United States, such as American College of Gastroenterology、Preventive Services Task Force, have updated guidelines for colorectal cancer screening in average-risk individuals. These guidelines have different recommendation levels in terms of starting and ending age, screening methods and frequency for colorectal cancer screening. A comprehensive understanding of the key points of these guideline updates and the similarities and differences recommended by different guidelines has important reference value for the colorectal cancer screening in China.
